Autonomic Nervous System Drugs Practice Questions

Q: Agonistic action at which of the following adrenergic receptors results in the reduction of aqueous humor secretion?

alpha-2 receptor. **Explanation:** The production and drainage of aqueous humor are regulated by the autonomic nervous system. To reduce intraocular pressure (IOP), pharmacological agents must either decrease secretion from the ciliary body or increase outflow through the trabecular or uveoscleral pathways. **Why Alpha-2 Agonists are Correct:** Alpha-2 ($\alpha_2$) receptors are primarily inhibitory G-protein coupled receptors ($G_i$). Agonism at these receptors on the ciliary epithelium leads to a decrease in intracellular cyclic AMP (cAMP). This reduction in cAMP inhibits the activity of the ciliary processes, thereby **decreasing aqueous humor secretion**. Additionally, some $\alpha_2$ agonists (like Brimonidine) also enhance uveoscleral outflow. **Analysis of Incorrect Options:** * **Beta-1 and Beta-2 receptors:** Stimulation of $\beta$-receptors (primarily $\beta_2$) in the ciliary body **increases** cAMP, which **promotes** aqueous secretion. This is why Beta-blockers (e.g., Timolol) are used to treat glaucoma—they block this stimulatory effect to reduce production. * **Muscarinic M2 receptor:** While M3 receptors are the primary targets in the eye (causing miosis and contraction of the ciliary muscle to increase trabecular outflow), M2 receptors are not the primary mediators for reducing aqueous secretion. **High-Yield Clinical Pearls for NEET-PG:** * **Brimonidine:** A highly selective $\alpha_2$ agonist. Key side effect: **Lid retraction** and **follicular conjunctivitis**. It is contraindicated in infants due to the risk of CNS depression/apnea. * **Apraclonidine:** Used primarily to prevent IOP spikes after laser procedures (e.g., YAG capsulotomy). * **Mechanism Summary:** * $\alpha_2$ Agonists: $\downarrow$ Production + $\uparrow$ Uveoscleral outflow. * $\beta$-Blockers: $\downarrow$ Production (only). * Prostaglandin Analogs (Latanoprost): $\uparrow$ Uveoscleral outflow (Most potent).

Q: All of the following drugs are useful in detrusor instability except?

Duloxetine. The clinical condition described, **detrusor instability** (also known as overactive bladder or urge incontinence), is characterized by involuntary contractions of the detrusor muscle during the filling phase. This muscle is primarily under **parasympathetic (M3 receptor)** control [1]. Therefore, the mainstay of treatment is **Antimuscarinic drugs**, which promote bladder relaxation. **Why Duloxetine is the Correct Answer:** * **Mechanism:** Duloxetine is a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. It works by increasing the tone of the external urethral sphincter via Pudendal nerve stimulation (Onuf’s nucleus). * **Clinical Use:** It is indicated for **Stress Urinary Incontinence (SUI)**—leakage during coughing or sneezing—rather than detrusor instability (urge incontinence). It does not directly relax the detrusor muscle. **Analysis of Incorrect Options:** * **Solifenacin & Tolterodine:** These are competitive **M3-selective antagonists** [2]. They are the first-line pharmacological treatments for detrusor instability as they reduce involuntary bladder contractions and increase bladder capacity [1]. * **Flavoxate:** This is a papaverine-like drug with direct **smooth muscle relaxant** properties and weak anticholinergic activity [1]. It is used to symptomatic relief of urinary spasms/urgency. **High-Yield NEET-PG Pearls:** 1. **Mirabegron:** A **$\beta_3$-agonist** used for overactive bladder; it relaxes the detrusor by mimicking sympathetic activity. 2. **Oxybutynin:** Often considered the "gold standard" antimuscarinic but has high side effects (dry mouth) due to lack of M3 selectivity [2]. 3. **Darifenacin/Solifenacin:** Preferred for their high M3 selectivity, leading to fewer systemic side effects [1]. 4. **Drug of Choice for Nocturnal Enuresis:** Desmopressin (DOC); Imipramine (historically used).

Q: Norepinephrine action at the synaptic cleft is terminated by which mechanism?

Reuptake. **Explanation:** The termination of Norepinephrine (NE) action at the synaptic cleft is primarily achieved through **Reuptake (Uptake-1)**. 1. **Why Reuptake is correct:** Approximately **75-90%** of the norepinephrine released into the synaptic cleft is rapidly removed by a high-affinity sodium-dependent transporter called the **Norepinephrine Transporter (NET)**. This process, known as **Uptake-1**, transports NE back into the presynaptic neuron. Once inside, it is either sequestered into vesicles for reuse or metabolized. This is the fastest and most significant mechanism for terminating its physiological effect. 2. **Why other options are incorrect:** * **Metabolism by COMT & MAO:** While Catechol-O-methyltransferase (COMT) and Monoamine oxidase (MAO) are responsible for the *metabolism* of catecholamines, they do not terminate the immediate synaptic action. COMT primarily handles circulating catecholamines in the liver and kidneys, while MAO is an intracellular enzyme located on the outer mitochondrial membrane. * **Metabolism by Acetylcholinesterase:** This enzyme is specific to the termination of **Acetylcholine** at cholinergic synapses (e.g., neuromuscular junctions) and has no role in adrenergic signaling. **High-Yield Clinical Pearls for NEET-PG:** * **Uptake-1 (Neuronal):** Inhibited by **Cocaine** and **Tricyclic Antidepressants (TCAs)**, leading to increased NE levels in the cleft (sympathomimetic effect). * **Uptake-2 (Extraneuronal):** A lower-affinity process where NE is taken up by non-neuronal cells (smooth muscle/endothelium); it is inhibited by corticosteroids. * **VMAT-2:** The transporter that pumps NE into storage vesicles; it is inhibited by **Reserpine**. * **Metabolite:** The major end-product of NE/Epinephrine metabolism excreted in urine is **VMA (Vanillylmandellic acid)**, which is a diagnostic marker for Pheochromocytoma.

Q: Which of the following drugs exhibits the phenomenon of vasomotor reversal of Dale after administration of an alpha-adrenergic blocker?

Adrenaline. **Explanation:** **Vasomotor Reversal of Dale** refers to the phenomenon where the typical pressor (blood pressure-increasing) effect of Adrenaline is converted into a depressor (blood pressure-lowering) effect following the administration of an alpha-blocker. **1. Why Adrenaline is correct:** Adrenaline is a potent agonist of **$\alpha_1, \alpha_2, \beta_1,$ and $\beta_2$** receptors. * **Normally:** Its $\alpha_1$-mediated vasoconstriction outweighs its $\beta_2$-mediated vasodilation, resulting in a net rise in blood pressure. * **After Alpha-blockade:** The $\alpha_1$ receptors are blocked. When Adrenaline is administered, only the **$\beta_2$ receptors** in the skeletal muscle blood vessels are available for activation. This leads to unopposed vasodilation, causing the blood pressure to fall instead of rise. **2. Why other options are incorrect:** * **Noradrenaline:** It acts primarily on $\alpha_1, \alpha_2,$ and $\beta_1$ receptors with **negligible effect on $\beta_2$**. Therefore, after alpha-blockade, there is no $\beta_2$ effect to cause vasodilation; the BP simply fails to rise (it stays near baseline). * **Isoprenaline:** It is a pure $\beta$-agonist ($\beta_1 + \beta_2$). It causes a fall in BP regardless of alpha-blockade because it has no alpha action to begin with. Thus, no "reversal" occurs. **High-Yield Clinical Pearls for NEET-PG:** * **Sir Henry Dale** first demonstrated this effect using ergot alkaloids (the first alpha-blockers). * **Key Concept:** For reversal to occur, the drug must have **both** alpha (constrictor) and beta-2 (dilator) properties. * **Clinical Relevance:** In patients with Pheochromocytoma, always give alpha-blockers *before* beta-blockers to avoid a hypertensive crisis caused by unopposed alpha-mediated vasoconstriction.

Q: Which of the following is NOT a contraindication to the use of beta-blockers?

Tachycardia. **Explanation:** Beta-blockers (β-adrenoceptor antagonists) work by blocking the effects of epinephrine and norepinephrine on beta receptors. Understanding their physiological effects is key to identifying their contraindications. **Why Tachycardia is the Correct Answer:** Beta-blockers are **indicated** (used for treatment), not contraindicated, in tachycardia. By blocking $\beta_1$ receptors in the sinoatrial (SA) node, they decrease the heart rate (negative chronotropic effect). They are first-line agents for rate control in conditions like sinus tachycardia, atrial fibrillation, and thyrotoxicosis. **Why the other options are Contraindications:** * **Bradycardia (Option A):** Since beta-blockers slow the heart rate, they can worsen pre-existing bradycardia or heart block, potentially leading to cardiac arrest. * **Bronchial Asthma (Option C):** Non-selective beta-blockers block $\beta_2$ receptors in the bronchial smooth muscle, leading to bronchoconstriction. This can precipitate a life-threatening asthma attack. (Note: Cardioselective $\beta_1$ blockers are preferred if a beta-blocker is absolutely necessary). * **Raynaud’s Disease (Option D):** Blocking $\beta_2$-mediated vasodilation leaves $\alpha$-mediated vasoconstriction unopposed. This worsens peripheral vasospasm and reduces cold tolerance in patients with peripheral vascular disease. **High-Yield Clinical Pearls for NEET-PG:** * **Diabetes Mellitus:** Beta-blockers are used with caution because they mask the warning symptoms of hypoglycemia (tachycardia/tremors), though sweating (mediated by cholinergic sympathetic nerves) remains. * **Prinzmetal Angina:** They are contraindicated as they may worsen coronary vasospasm due to unopposed $\alpha$-activity. * **Cardioselectivity:** Remember the mnemonic **"A to M"** (e.g., Atenolol, Metoprolol) for $\beta_1$ selective blockers, which are safer (but not absolute) in respiratory or peripheral vascular issues.

Q: Pupillary dilatation is seen in which of the following drug classes?

Belladonna alkaloids. **Explanation:** The correct answer is **Belladonna alkaloids** (Option B). **1. Why Belladonna alkaloids are correct:** Belladonna alkaloids, such as **Atropine** and Scopolamine, are competitive antagonists of muscarinic acetylcholine receptors. In the eye, they block the M3 receptors on the circular muscle (sphincter pupillae) of the iris. This prevents parasympathetic-mediated pupillary constriction, leading to unopposed action of the radial muscle (dilator pupillae), resulting in **Mydriasis** (pupillary dilatation). They also cause cycloplegia (paralysis of accommodation) by blocking M3 receptors on the ciliary muscle. **2. Why other options are incorrect:** * **Organophosphorus compounds (A):** These are irreversible acetylcholinesterase inhibitors. They lead to an accumulation of acetylcholine at the motor endplate and synapses, causing excessive stimulation of M3 receptors, which results in **pinpoint pupils (Miosis)**. * **Heroin (C) and Morphine (D):** Both are opioids that stimulate the Edinger-Westphal nucleus (parasympathetic nucleus of the oculomotor nerve). This central stimulation leads to intense pupillary constriction, classically described as **"pinpoint pupils."** **Clinical Pearls for NEET-PG:** * **Mydriasis (Dilated pupils):** Seen in "Sympathomimetics" (Cocaine, Amphetamines) and "Anticholinergics" (Atropine, Datura). * **Miosis (Constricted pupils):** Remember the mnemonic **"P-O-N-S"** (Pontine hemorrhage, Opioids, Nicotine/Nerve gas, Sedatives/Sartans/Strychnine). * **Diagnostic Tip:** In a comatose patient, pinpoint pupils that are non-reactive to light strongly suggest **Opioid poisoning** or a **Pontine infarct**. * **Atropine** is the specific antidote for Organophosphorus poisoning to reverse the life-threatening muscarinic effects.

Q: Which of the following drugs primarily increases uveo-scleral outflow?

Latanoprost. **Explanation:** The management of Glaucoma involves reducing intraocular pressure (IOP) by either decreasing aqueous humor production or increasing its drainage. Drainage occurs via two pathways: the **Trabecular meshwork** (conventional) and the **Uveoscleral pathway** (unconventional). **Why Latanoprost is correct:** **Latanoprost** is a PGF2α analogue. It is the drug of choice for Open Angle Glaucoma. It works primarily by increasing the **uveoscleral outflow** of aqueous humor by relaxing the ciliary muscle and remodeling the extracellular matrix. **Analysis of Incorrect Options:** * **Apraclonidine:** An alpha-2 agonist. It primarily works by **decreasing aqueous humor production** and, to a lesser extent, increasing trabecular outflow. * **Timolol:** A non-selective beta-blocker. It is a traditional first-line agent that works solely by **decreasing aqueous humor production** from the ciliary epithelium. * **Brinzolamide:** A topical Carbonic Anhydrase Inhibitor (CAI). It reduces IOP by **decreasing the secretion** of aqueous humor (bicarbonate ions) from the ciliary body. **NEET-PG High-Yield Pearls:** * **Prost** drugs (Latanoprost, Bimatoprost, Travoprost) are the most potent drugs for lowering IOP. * **Side effects of Prostaglandins:** Increased pigmentation of the iris (heterochromia iridis), thickening/darkening of eyelashes (trichomegaly), and cystoid macular edema. * **Miotics (Pilocarpine)** increase **trabecular** outflow by contracting the ciliary muscle. * **Drug of choice for Acute Angle Closure Glaucoma:** IV Acetazolamide/Mannitol (to rapidly lower pressure before surgery).

Q: All of the following are nonselective beta-blockers with additional actions, except?

Betoxalol. **Explanation** The question tests the classification of beta-blockers based on their receptor selectivity and additional pharmacological properties (Vasodilatory or Pleiotropic effects). **1. Why Betaxolol is the correct answer:** Betaxolol is a **highly selective $\beta_1$-blocker** (second generation). It does not belong to the nonselective category. While it is used topically in glaucoma due to its membrane-stabilizing activity, it lacks the significant "additional" vasodilatory actions (like $\alpha$-blockade or nitric oxide release) characteristic of the third-generation beta-blockers listed in the other options. **2. Analysis of Incorrect Options:** * **Carvedilol:** A nonselective $\beta$-blocker with **$\alpha_1$-blocking** activity. It also possesses antioxidant and calcium-channel blocking properties, making it a mainstay in chronic heart failure management. * **Carteolol:** A nonselective $\beta$-blocker with **Intrinsic Sympathomimetic Activity (ISA)**. It is unique because it also acts as a $\beta_2$-agonist, which helps in reducing intraocular pressure while potentially causing less bradycardia. * **Labetalol:** A nonselective $\beta$-blocker with additional **$\alpha_1$-blocking** activity (ratio of $\alpha:\beta$ is 1:3 for oral and 1:7 for IV). It is a drug of choice for hypertensive emergencies and pregnancy-induced hypertension. **Clinical Pearls for NEET-PG:** * **Third-generation Vasodilatory Beta-blockers:** * *Nonselective:* Labetalol, Carvedilol, Carteolol, Bucindolol. * *$\beta_1$ Selective:* Nebivolol (via NO release), Celiprolol, Betaxolol (minimal). * **Nebivolol** is the most $\beta_1$-selective blocker currently available. * **Esmolol** is the shortest-acting $\beta$-blocker (half-life ~9 mins) due to metabolism by RBC esterases. * **Sotalol** is a nonselective $\beta$-blocker that also acts as a Class III antiarrhythmic (K+ channel blocker).

Question 1

Agonistic action at which of the following adrenergic receptors results in the reduction of aqueous humor secretion?

Accepted Answer

alpha-2 receptor

Answer

beta-1 receptor

Answer

beta-2 receptor

Answer

muscarinic M2 receptor

Question 2

All of the following agents are used in glaucoma treatment, except?

Accepted Answer

Metoprolol

Answer

Apraclonidine

Answer

Timolol

Answer

Pilocarpine

Question 3

All of the following drugs are useful in detrusor instability except?

Accepted Answer

Duloxetine

Answer

Solefenacin

Answer

Tolterodine

Answer

Flavoxate

Question 4

Norepinephrine action at the synaptic cleft is terminated by which mechanism?

Accepted Answer

Reuptake

Answer

Metabolism by COMT

Answer

Metabolism by MAO

Answer

Metabolism by acetylcholinesterase

Question 5

Which of the following drugs exhibits the phenomenon of vasomotor reversal of Dale after administration of an alpha-adrenergic blocker?

Accepted Answer

Adrenaline

Answer

Noradrenaline

Answer

Isoprenaline

Answer

All of the above

Question 6

Which of the following is NOT a contraindication to the use of beta-blockers?

Accepted Answer

Tachycardia

Answer

Bradycardia

Answer

Bronchial asthma

Answer

Raynaud's disease

Question 7

Tolazoline is used as:

Accepted Answer

A vasodilator in treating coronary artery stenosis during angio procedures

Answer

A thrombin inhibitor in peripheral angiography

Answer

A vasoconstrictor in treatment of varices

Answer

An antispasmodic during biliary spasm

Question 8

Pupillary dilatation is seen in which of the following drug classes?

Accepted Answer

Belladonna alkaloids

Answer

Organophosphorus compounds

Answer

Heroin

Answer

Morphine

Question 9

Which of the following drugs primarily increases uveo-scleral outflow?

Accepted Answer

Latanoprost

Answer

Apraclonidine

Answer

Timolol

Answer

Brinzolamide

Question 10

All of the following are nonselective beta-blockers with additional actions, except?

Accepted Answer

Betoxalol

Answer

Carvedilol

Answer

Caeolol

Answer

Labetalol

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?